Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Alzheimer Disease

SHIELD: A simple, memorable model to help prevent Alzheimer’s disease and dementia

Alzheimer’s disease (AD) is on track to become one of the defining public health challenges of our time. Every three seconds, somewhere in the world, someone is diagnosed with dementia, and it’s usually Alzheimer’s disease.

The Conversation

Scientists design a new digital test to diagnose Alzheimer’s

Experts believe new test could give doctors a chance to identify potential dementia cases earlier

The Independent UK

NHS to trial revolutionary blood test that could speed up Alzheimer’s diagnosis

Only two-thirds of people with dementia have a diagnosis, despite it being the leading cause of death in UK

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

British patients trial major new blood test for Alzheimer’s disease

Alzheimer’s disease is the most common cause of dementia and linked to the build-up of two key proteins in the brain called amyloid and tau.

Evening Standard

Air pollution has been tied to Alzheimer’s disease. Here’s what you need to know

‘Air pollution doesn’t just increase the risk of dementia — it actually makes Alzheimer’s disease worse,’ Dr. Edward Lee says

The Independent UK

Alzheimer’s disease: new three-minute test can spot memory issues – here’s how it works and what it can tell you

A new test could help to diagnose memory issues associated with Alzheimer’s disease in as little as three minutes. According to recently published findings the test, called the Fastball EEG test, may one day help doctors flag people who need further checks for Alzheimer’s disease without the need for unnecessary…

The Conversation

5 early signs of Alzheimer’s you shouldn’t ignore

It’s crucial to consult a doctor if you notice these symptoms are interfering with daily life

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Three-minute test helps identify people at greater risk of Alzheimer’s, trial finds

Test detects memory problems linked to Alzheimer’s long before typical diagnosis, raising possibility of earlier drug intervention

The Guardian - UK

The popular supplement that could protect women from Alzheimer’s disease

Researchers say clinical trials are needed to determine the biological trajectory of Alzheimer’s disease

The Independent UK

Women with Alzheimer’s have unusually low omega fatty acid levels, study finds

Analysis of blood samples finds women with the disease have 20% lower levels, a pattern not seen in men

The Guardian - UK

Cheap supplement may protect against Alzheimer’s in women

People can get omega fatty acids as a supplement or by eating salmon, mackerel or sardines.

Evening Standard

The mineral that could protect against Alzheimer’s disease

For nearly a decade, scientists from Harvard University have also been uncovering lithium’s unexpected importance in the brain

The Independent UK

The vaccine that could lower the risk of dementia by 20 per cent

A new study could change the way we understand and treat dementia and other degenerative disorders of the brain

The Independent UK

Vaccines hold tantalizing promise in the fight against dementia

Over the past two centuries, vaccines have been critical for preventing infectious diseases. The World Health Organization estimates that vaccination prevents between 3 million and 5 million deaths annually from diseases like diphtheria, tetanus, influenza, measles and, more recently, COVID-19.

The Conversation

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Eli Lilly's Early Alzheimer's Drug Recommended For Approval By European Drug Regulator's Panel

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion on Friday recommending Eli Lilly and Co.’s (NYSE:LLY) donanemab for early symptomatic Alzheimer’s disease in adults with confirmed amyloid pathology who are apolipoprotein E ε4 (ApoE4) heterozygotes or non-carriers.

The Independent UK

Blood tests could reveal early signs of Alzheimer’s disease, research suggests

Researchers say the findings provide new insights into possible early indicators of Alzheimer’s disease

Investors Business Daily

Acadia Emerges From Behind The Scenes With A Potential $12 Billion Opportunity

Acadia Pharmaceuticals is working on its next-generation Nuplazid and, for CEO Catherine Owen Adams, the journey is personal.

The Independent UK

Women are twice as likely to suffer from Alzheimer’s as men. Scientists have figured out why

One in three older Americans dies with Alzheimer's or another dementia

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

High levels of Alzheimer‘s-linked protein found in healthy newborn babies

For years, scientists have assumed high levels of p-tau217 always spell trouble. The new research suggests they’ve been wrong

The Conversation

Babies have more of this Alzheimer’s-linked protein than dementia patients – study raises hope for future treatments

A protein long blamed for the brain damage seen in Alzheimer’s disease has now been found in astonishingly high levels in healthy newborn babies, challenging decades of medical dogma.

International Business Times UK

Scientists Shocked to Find Alzheimer's Biomarker in Newborn Brains: A Groundbreaking Discovery Offering Hope for Early Intervention

Scientists have discovered an Alzheimer's biomarker in newborn brains for the first time. This breakthrough could lead to earlier detection and prevention of Alzheimer's disease.

The Independent UK

Breast cancer survivors may have a lower risk of Alzheimer’s disease, experts say

South Korean researchers say they had found an 8 percent lower risk

The Independent UK

Gut bacteria may hold key to protecting brain against Alzheimers

A bacteria best known for causing stomach ulcers could lead to a new strategy in the fight against Alzheimer’s disease

Evening Standard

Alzheimer’s drugs rejected for NHS because benefits ‘too small’ to justify cost

Donanemab and lecanemab are targeted antibody drugs that slow down the early stages of Alzheimer’s.

The Independent UK

Breakthrough Alzheimer’s drugs rejected for use on the NHS. Here’s how they work

Scientists and doctors remain divided on the targeted antibody drugs that slow down the early stages of Alzheimer’s

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the World Health Organization

Alzheimer Research UK

137 stories

Harvard Medical School

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.